XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders' Equity
12 Months Ended
Jun. 30, 2023
Federal Home Loan Banks [Abstract]  
Shareholders' Equity

10. SHAREHOLDERS’ EQUITY

Employee and Directors Stock Option PlansThe 2011 Director Stock Option Plan was approved by SunLink’s shareholders at the Annual Meeting of Shareholders on November 7, 2011. This plan permits the grant of options to non-employee directors of SunLink for the purchase of up to 300,000 common shares through November 2021. No options were granted during the fiscal years ended June 30, 2023 and 2022, respectively. Options for 105,000 shares and 30,000 shares were exercised during the fiscal year ended June 30, 2023 and 2022, respectively. Options outstanding under the plan were 95,000 shares at June 30, 2023. No additional awards may be granted under this plan.

The 2005 Equity Incentive Plan approved by SunLink’s shareholders on November 7, 2005 permitted the grant of options to employees, non-employee directors and service providers of SunLink for the purchase of up to 800,000 common shares plus the number of unused shares under its 2001 Plans, which were 30,675. Options for 90,000 common shares were exercised during the fiscal year ended June 30, 2023. No options have been exercised under this Plan during the fiscal year ended June 30, 2022. No option shares were granted during the fiscal years ended June 30, 2023 and 2022, respectively. Options outstanding under this Plan were 90,000 at June 30, 2023. No additional awards may be granted under this plan.

The activity of Company’s share options is shown in the following table:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise Price

 

 

Range of
Exercise
Prices

 

Options outstanding June 30, 2021

 

 

410,000

 

 

$

1.34

 

 

$0.71-$1.79

 

Granted

 

 

0

 

 

NA

 

 

NA

 

Exercised

 

 

(30,000

)

 

$

1.67

 

 

$

1.67

 

Options outstanding June 30, 2022

 

 

380,000

 

 

$

1.31

 

 

$0.71-$1.79

 

Granted

 

 

0

 

 

NA

 

 

NA

 

Exercised

 

 

(195,000

)

 

 

1.22

 

 

$0.71-$1.38

 

Options outstanding June 30, 2023

 

 

185,000

 

 

$

1.41

 

 

$0.71 - $1.79

 

Options exercisable June 30, 2022

 

 

380,000

 

 

$

1.31

 

 

$0.71 - $1.79

 

Options exercisable June 30, 2023

 

 

185,000

 

 

$

1.41

 

 

$0.71 - $1.79

 

 

For the fiscal years ended June 30, 2023 and 2022 , the Company recognized no compensation expense for share options issued. As of June 30, 2023 and 2022, there was no unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plans.

Information with respect to stock options outstanding and exercisable at June 30, 2023 is as follows:

 

Exercise
Prices

 

 

Number
Outstanding

 

 

Weighted-Average
Remaining
Contractual Life
(in years)

 

 

Number
Exercisable

 

$

0.71

 

 

 

9,000

 

 

 

0.21

 

 

 

9,000

 

$

1.21

 

 

 

36,000

 

 

 

3.21

 

 

 

36,000

 

$

1.38

 

 

 

30,000

 

 

 

6.20

 

 

 

30,000

 

$

1.49

 

 

 

90,000

 

 

 

1.21

 

 

 

90,000

 

$

1.79

 

 

 

20,000

 

 

 

2.20

 

 

 

20,000

 

 

 

 

 

185,000

 

 

 

2.46

 

 

 

185,000

 

 

Options for 195,000 shares were exercised during the year ended June 30, 2023. Options for 30,000 shares were exercised during the year ended June 30, 2022. As of June 30, 2023 and 2022, the aggregate intrinsic value of options outstanding and options exercisable were $3 and $3, respectively.

 

Accumulated Other Comprehensive Income (Loss) —Information with respect to the balances of each classification within accumulated other comprehensive income is as follows:

 

 

 

Minimum
Pension
Liability
Adjustment

 

 

Accumulated
Other
Comprehensive
Income (Loss)

 

June 30, 2021

 

$

(162

)

 

$

(162

)

Current period change

 

 

268

 

 

 

268

 

June 30, 2022

 

$

106

 

 

$

106

 

Current period change

 

 

44

 

 

 

44

 

June 30, 2023

 

$

150

 

 

$

150